Your browser does not support SVG.
July 12, 2018
Roivant subsidiary Dermavant Sciences signs agreem ...
Dermavant Sciences to Present New Data on Cerdulatinib for Atopic Dermatitis and Vitiligo at the 3rd Annual Inflammatory Skin Disease Summit
Dermavant Appoints Todd Zavodnick as Chief Executive Officer
Dermavant Sciences to Present Tapinarof Phase 2B Data on Patient-Reported Outcomes for Psoriasis and Atopic Dermatitis at the Fall Clinical Dermatology Conference
Dermavant Announces Changes to Leadership and Board of Directors
Dermavant Sciences Announces Closing of Transaction with GSK for Purchase of Rights to Tapinarof